HealthEquity Shares Drop Despite Beating Earnings Estimates
Despite reporting better-than-expected earnings and revenue for its second fiscal quarter, HealthEquity (NASDAQ: HQY) experienced a significant stock price decline of up to 12% during the week. The company reported non-GAAP earnings per share of $1.24 on sales of $350.7 million — both exceeding Wall Street forecasts. However, investors appeared disappointed with only marginal guidance updates for full-year revenue and adjusted EPS that did not exceed expectations by a wide margin. HealthEquity's stock had been near its 52-week high before the earnings report but fell sharply after results were released on Thursday. The company raised its annual sales target slightly to between $1.411 billion and $1.421 billion, while maintaining adjusted EPS guidance of $4.66–$4.73 — both in line with or just above analyst estimates. The sell-off suggests that investors were expecting stronger performance from the healthcare financial services provider despite its solid quarterly results.
Tickers: $HQY